Ramathibodi Hospital

Futó vizsgálatok

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight

  NCT07668401· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

  NCT07298421· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

  NCT07413939· 2/3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  NCT07400107· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  NCT07415954· 2. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

  NCT07158242· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07351058· 3. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS)

  NCT07390006· Mahidol University· Forrás

• Toboroz

  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

  NCT07332481· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  NCT07318558· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  SnapDandCGMinType2DM

  NCT07533604· Ramathibodi Hospital· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  NCT07216703· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

  NCT06847542· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  NCT06765109· 3. fázis· Nuvalent Inc.· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm

  NCT06991517· World Health Research Inc.· Forrás

• Toboroz

  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  NCT06499285· 3. fázis· Takeda· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  NCT06824467· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  NCT06750094· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

  NCT06700096· 3. fázis· Biocad· Forrás

• Fut, nem toboroz

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás

• Meghívásos bevonás

  Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus

  NCT06475742· 3. fázis· Viatris Innovation GmbH· Forrás

• Toboroz

  Thailand ATTR-CM Registry

  NCT06338696· Mahidol University· Forrás

• Toboroz

  A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  NCT06056297· 3. fázis· X4 Pharmaceuticals· Forrás

• Toboroz

  COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

  NCT06396299· Mahidol University· Forrás

• Toboroz

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· 2/3. fázis· CSL Behring· Forrás

• Fut, nem toboroz

  A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus

  NCT05835986· 1. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

  NCT05904886· 3. fázis· Hoffmann-La Roche· Forrás

• Meghívásos bevonás

  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  NCT05979441· 3. fázis· argenx· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

  NCT05555732· 3. fázis· Daiichi Sankyo· Forrás

• Fut, nem toboroz

  A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

  NCT05648500· 3. fázis· Viatris Innovation GmbH· Forrás

• Fut, nem toboroz

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

  NCT05330325· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

  NCT05296798· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

  NCT05135559· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· 3. fázis· Otsuka Pharmaceutical Development & Commercialization, Inc.· Forrás

• Fut, nem toboroz

  A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

  NCT05239728· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)

  NCT04770753· 3. fázis· Agios Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

  NCT04770779· 3. fázis· Agios Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

  NCT04893291· Fondazione Ricerca e Innovazione Cardiovascolare ETS· Forrás

• Fut, nem toboroz

  A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

  NCT04929210· 4. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection

  NCT04925752· 3. fázis· Gilead Sciences· Forrás

Showing 50 of 68.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• 2-es típusú cukorbetegség4 toboroz
• Elhízás3 toboroz
• Lupus (SLE)3 toboroz
• Peripheral artery disease3 toboroz
• Dermatomyositis and polymyositis (myositis)2 toboroz
• Koszorúér-betegség2 toboroz
• Krónikus vesebetegség2 toboroz
• Petefészekrák2 toboroz
• Stroke (szélütés)2 toboroz
• Amiloidózis1 toboroz
• Aortic stenosis1 toboroz
• Áttétes emlőrák1 toboroz
• Bronchiectasis1 toboroz
• Colitis ulcerosa1 toboroz
• Crohn-betegség1 toboroz
• Gyermekkori daganatok1 toboroz
• Hemofília1 toboroz
• Időskori makuladegeneráció1 toboroz
• Magas vérnyomás1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Pitvarfibrilláció1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Szívelégtelenség1 toboroz
• Tüdőrák1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Visszavonták

  A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

  NCT07357766· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  How a Plant-Based Diet Affects Blood Pressure and Gut Health in Kidney Transplant Patient

  NCT06871722· Mahidol University· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás

• Visszavonták

  Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes

  NCT06083675· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

  NCT06010303· 2. fázis· BeiGene· Forrás

• Lezárult

  A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes

  NCT05813912· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

  NCT05909904· 2. fázis· BeiGene· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· 3. fázis· LG Chem· Forrás

• Lezárult

  A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

  NCT05394519· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma

  NCT05564052· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

  NCT05586958· 3. fázis· LG Chem· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity

  NCT04998136· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

  NCT06285110· University of Bern· Forrás

• Lezárult

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· 3. fázis· Amgen· Forrás

• Lezárult

  Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy

  NCT05044845· St. Jude Children's Research Hospital· Forrás

• Lezárult

  Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes

  NCT05070949· Mahidol University· Forrás

• Lezárult

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)

  NCT04891770· 2. fázis· Gilead Sciences· Forrás

• Lezárult

  A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

  NCT04785820· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck

  NCT04665843· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

  NCT04540211· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

  NCT04543617· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

  NCT04513925· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

  NCT04294810· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

  NCT04248829· 3. fázis· Yuhan Corporation· Forrás

• Lezárult

  Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

  NCT04215978· 1. fázis· BeiGene· Forrás

• Lezárult

  Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

  NCT04003636· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

  NCT03924856· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

  NCT03894215· 2. fázis· Agenus Inc.· Forrás

• Lezárult

  Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

  NCT03867084· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

  NCT03797326· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

  NCT03674567· 1/2. fázis· RAPT Therapeutics, Inc., a member of the GSK plc group of companies· Forrás

• Lezárult

  Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

  NCT03547908· 3. fázis· Gilead Sciences· Forrás

• Lezárult

  Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants

  NCT03315455· 3. fázis· Hoffmann-La Roche· Forrás

• Leállították

  A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

  NCT03452137· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· 3. fázis· CSL Behring· Forrás

• Lezárult

  Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

  NCT03072238· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

  NCT02838420· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Cryo Global Registry

  NCT02752737· Medtronic Cardiac Ablation Solutions· Forrás

• Lezárult

  A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

  NCT02615691· 3. fázis· Baxalta now part of Shire· Forrás

• Lezárult

  A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

  NCT02297438· 3. fázis· Pfizer· Forrás

• Lezárult

  Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

  NCT02303821· 1. fázis· Amgen· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Thalassaemia8 munka · 2 vizsgálat
• Dermatomyositis and polymyositis (myositis)5 munka · 3 vizsgálat